CYTOSORBENTS MEDICAL INC — Department of Defense STTR Phase I: DHP15B-001
CYTOSORBENTS MEDICAL INC — STTR Phase I award from Department of Defense.
Phase I STTR feasibility signal
- Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from Department of Defense in a technical approach.
- Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
- Obligated amount $149,979. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Topic code DHP15B-001 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $149,979
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- STTR · Phase I
- Topic
- DHP15B-001
- Solicitation
- 2015.0
- NAICS
- —
- Place of performance
- NJ
- Period
- 2016-04-19 → 2016-11-18
Description
The ready availability of universal donor plasma to rapidly treat massively bleeding hospital trauma patients and warfighters with combat casualties is a key element of current recommendations for trauma resuscitation, yet universal AB donor plasma is rel